Meridian Bioscience (VIVO) Prelim. Q3 Revenue Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 2.42 +0.14 (6.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.28 | 52 Week High | $21.49 | |||
| Open | $2.24 | 52 Week Low | $15.75 | |||
| Day High | $2.44 | P/E | 2.75 | |||
| Day Low | $2.20 | EPS | $0.88 | |||
| Volume | 562,605 | |||||
